A 148 Average Glucose: What A1C Level Is It?

An average glucose of 148 mg/dL translates to an A1C of roughly 6.8%, based on the widely used conversion formula developed by the international A1C-Derived Average Glucose (ADAG) study. That places you just above the 6.5% threshold used to diagnose diabetes and below the 7.0% target that most guidelines set for people already managing the condition. The number sits in a clinically meaningful zone, and how your body arrives at that average matters as much as the average itself.

How the Conversion Formula Works

The relationship between A1C and average blood glucose was pinned down in a landmark study that tracked participants wearing continuous glucose monitors while also getting lab-drawn A1C tests. The resulting formula is straightforward: estimated average glucose in mg/dL equals 28.7 multiplied by the A1C value, minus 46.7. The correlation was strong, and the formula has become the standard way to translate between the two numbers.¹ Plugging in an average glucose of 148 and solving backward gives an A1C of about 6.8%. For reference, an A1C of 6.5% corresponds to an estimated average glucose of about 140 mg/dL, and 7.0% corresponds to about 154 mg/dL.²

Professional diabetes organizations now encourage labs to report estimated average glucose alongside A1C, because most people check their blood sugar in mg/dL (or mmol/L outside the U.S.) and find that scale more intuitive. An A1C of 6.8% can feel abstract; “your average glucose has been about 148” clicks immediately for someone who sees numbers on their meter every day.

Why 148 Lands in an Important Range

A 148 mg/dL average is not a crisis, but it is not a number to ignore. The 6.5% A1C mark is the diagnostic cutoff for type 2 diabetes, and 7.0% is the treatment target most guidelines recommend for adults who already have the diagnosis. At 6.8%, you are squarely between those two numbers. If you have already been diagnosed, your glucose control is close to goal but not quite there. If you have not been formally diagnosed, this result would itself meet the diagnostic criterion.

Staying consistently below 7.0% has real consequences for long-term health. Research following people with diabetes over years shows that both the mean A1C level and how long a person stays within a target range predict the risk of complications affecting the eyes, kidneys, and blood vessels.³ Swings in A1C over time add risk on top of the average itself. In the Diabetes Control and Complications Trial, each one-percentage-point increase in A1C variability more than doubled the hazard for retinopathy and raised the hazard for kidney disease by about 80%.⁴ So a steady A1C near 6.8% is better than one that bounces between 6.0% and 7.5%, even if the averages look similar on paper.

What “Average Glucose” Is Really Averaging

Your blood sugar is not one number. It spikes after meals, dips overnight, and varies throughout the day. The 148 mg/dL figure is a weighted blend of fasting glucose and all those post-meal surges, and the two components do not contribute equally at every A1C level.

When A1C is in the range you are dealing with (below about 7.3%), post-meal glucose is the dominant driver, accounting for roughly 70% of the overall A1C. As A1C climbs higher, fasting glucose becomes more important and post-meal glucose’s share shrinks to around 30%.⁵ A separate study found that post-meal glucose rises at about four times the rate of fasting glucose for each unit increase in A1C.⁶

This matters practically. If your fasting numbers look decent but your A1C is still 6.8%, the culprit is almost certainly what happens after you eat. Reducing those post-meal spikes, whether through dietary changes, timing of medication, or physical activity after meals, is likely the most efficient path to nudging your A1C closer to target. People with higher A1C levels have a different problem: their fasting glucose is the bigger lever to pull.

Data from insulin-treated populations confirms that lowering fasting glucose and post-meal glucose each independently reduce A1C, though the size of the effect differs by diabetes type and treatment regimen.⁷

When Your Meter or CGM Tells a Different Story

If you wear a continuous glucose monitor, you may have noticed a number called the Glucose Management Indicator, or GMI, which is the CGM’s own estimate of what your A1C “should” be based on the sensor readings. GMI and lab-drawn A1C do not always agree, and the gap can be confusing.

In a study of adults with type 2 diabetes wearing CGMs, about 56% of paired A1C and GMI readings fell within half a percentage point of each other. That means nearly half differed by more than that.⁸ People not using insulin tended to have slightly better agreement, while those on basal or basal-bolus insulin saw more mismatch. At the extremes of the A1C range (very low or very high), concordance dropped further. A smaller clinic-based study found that, on average, lab A1C ran about a third of a percentage point higher than CGM-derived GMI.⁹

So if your CGM says your average glucose is 148 and estimates your GMI at 6.8%, your actual lab A1C could come back anywhere from about 6.5% to 7.1% without anything being “wrong” with either measurement. They are measuring slightly different things. CGM captures interstitial glucose readings every few minutes for two or three weeks. A1C reflects the cumulative glucose exposure of your red blood cells over roughly two to three months, and it is affected by biological factors that have nothing to do with blood sugar.

Biological Factors That Shift A1C Without Changing Glucose

A1C measures glucose stuck to hemoglobin inside your red blood cells. Anything that changes how long those cells live, how much hemoglobin they carry, or how readily hemoglobin picks up glucose can push your A1C reading up or down independent of what your blood sugar actually did.

Red blood cells typically circulate for about 120 days. Conditions that shorten that lifespan, such as hemolytic anemias, heavy bleeding, or receiving a blood transfusion, lower A1C because the cells have less time to accumulate sugar. Conditions that extend red cell lifespan or slow their turnover, such as iron deficiency anemia (before treatment) or certain vitamin deficiencies, can inflate A1C. Kidney disease complicates interpretation in multiple ways: altered red cell survival, erythropoietin therapy, and shifts in how the body handles glucose all contribute to unreliable A1C readings.¹⁰

Hemoglobin variants add another layer of complexity. People who carry sickle cell trait, for instance, can get wildly different A1C results depending on which lab technique is used. One case showed an A1C of 10.1% by one method and 7.6% by another, despite the same glucose exposure.¹¹ A study comparing three different assay systems in people with sickle cell trait found differences between platforms as large as 0.8 percentage points.¹² If you have a known hemoglobin variant, talk to your doctor about which assay method your lab uses, because the standard conversion to average glucose may not apply to you at all.

Pregnancy and Iron Deficiency

Pregnancy changes blood volume, red cell production, and iron stores in ways that can make A1C unreliable. Iron deficiency anemia is common in pregnant women, and a systematic review highlighted that interpreting A1C in the presence of iron deficiency during pregnancy is genuinely complicated because of the simultaneous physiological shifts in blood volume and red cell turnover. The review concluded that A1C should not be the sole tool for managing blood sugar in pregnant women with iron deficiency.¹³

That said, a study examining how different degrees of anemia affect A1C in pregnancy found that mild and moderate anemia produced differences too small to matter clinically (the changes stayed below the 0.5% threshold considered meaningful in practice). The more interesting finding was that a red blood cell characteristic called mean corpuscular hemoglobin correlated independently with A1C levels, regardless of trimester or anemia severity, hinting at a mechanism beyond simple glucose exposure.¹⁴ For most pregnant women with mild anemia, A1C is still useful. For women with severe iron deficiency or hemoglobin disorders, alternative markers are safer to rely on.

Racial Differences in the A1C-Glucose Relationship

The conversion formula treats everyone the same, but the biology is not identical across populations. A study using continuous glucose monitoring found that, at the same average glucose level, Black participants had A1C values about 0.4 percentage points higher than white participants. Put differently, a Black person with a lab A1C of 6.8% might have an actual average glucose closer to what a white person with a 6.4% A1C experiences.¹⁵ The likely explanation involves differences in how readily hemoglobin undergoes glycation, not in glucose levels themselves.

This finding has been replicated and extended to other ethnic groups. Research has explored whether differences in red cell survival, the balance of glucose inside and outside cells, or genetic variation in hemoglobin glycation rates drive the discrepancy, but no single cause has been definitively established.¹⁶ The practical concern is that using A1C alone for diagnosis could systematically overdiagnose diabetes in some populations and underdiagnose it in others. If you are in a group where the standard conversion is known to run high, that “148 average glucose” implied by your A1C may actually be lower than 148.

How Age Nudges A1C Upward

A1C tends to creep up with age even in people who do not have diabetes. This is partly because insulin sensitivity declines and glucose regulation gradually worsens over decades. But some of the rise appears to be independent of actual blood sugar changes. As people age, red blood cell production and turnover slow down, which means each cell circulates longer and accumulates more sugar on its hemoglobin. Decreased macrophage function, which normally clears aging red blood cells, may further extend their lifespan. On top of that, structural changes to older red blood cells, such as reduced membrane lipids and greater cell fragility, may accelerate the glycation process itself.¹⁷

This means that a 70-year-old with a true average glucose of 148 mg/dL might show an A1C slightly higher than the predicted 6.8%, not because their sugar control is worse, but because their red blood cells are older and stickier. Conversely, a 25-year-old with the same average glucose might land slightly below 6.8%. The standard formula was not calibrated to account for age, so it works best as an approximation rather than a precise translation for any individual.

Lab Accuracy Is Not a Given

You might assume that a lab result of 6.8% is exact, but A1C measurement has its own margin of error. The National Glycohemoglobin Standardization Program (NGSP) and the International Federation of Clinical Chemistry (IFCC) have spent decades harmonizing A1C methods worldwide, and lab-based assays certified under these programs are generally trustworthy and interchangeable.¹⁸¹⁹

Point-of-care devices, the ones used in a doctor’s office for a quick result during your appointment, are a different story. An independent evaluation of 19 point-of-care A1C devices found that only 5 met both IFCC and NGSP certification criteria. Among the 14 devices that held current NGSP certification, 9 actually failed when tested against reference methods.²⁰ If your A1C was measured by a rapid office test and the number seems off compared to your home glucose readings, a follow-up lab draw may be warranted before making treatment decisions.

Glycemic Variability and What the Average Hides

An average glucose of 148 could represent steady readings that hover between 130 and 170 all day, or it could represent wild swings from 60 to 280 that happen to average out. Those two patterns carry very different health implications. Glycemic variability, the degree to which your glucose bounces around, has been linked to oxidative stress, blood vessel damage, and inflammation independent of what the average reads.²¹

A1C cannot capture variability. It is, by design, an average. If you want to know whether your glucose is stable or rollercoastering, you need time-series data, either from a CGM or from structured finger-stick testing at multiple points in the day. For someone sitting at 148 and a 6.8% A1C, the question is not just “can I get this lower?” but “how bumpy is the ride?”

Alternative Markers When A1C Falls Short

When A1C is unreliable because of hemoglobin variants, kidney disease, recent blood loss, or pregnancy, clinicians sometimes turn to other glycemic markers. Fructosamine measures glucose attached to all plasma proteins (mainly albumin) and reflects average glucose over roughly two to three weeks rather than two to three months. It correlates with CGM-derived mean glucose and can serve as a useful short-term check.²²

Glycated albumin is a subfraction of fructosamine that specifically measures glucose bound to albumin. Emerging data suggest it outperforms total fructosamine for diagnosing abnormal glucose tolerance.²³ In a treatment study, a drop of at least one percentage point in glycated albumin at four weeks predicted a clinically meaningful A1C reduction at twelve weeks, and glycated albumin tracked real-time changes in self-monitored glucose more closely than A1C did.²⁴ Neither marker is as widely available or as well standardized as A1C, but if your doctor suspects your A1C is being distorted, these alternatives can fill the gap.

Diet and Physical Activity at This A1C Level

At an A1C of 6.8%, lifestyle changes can make a real difference. Research in people with type 2 diabetes shows that higher diet quality scores are associated with lower A1C, and physical activity independently contributes as well.²⁵ Given that post-meal glucose dominates A1C in this range (as discussed earlier), the most efficient dietary strategies focus on blunting post-meal spikes: choosing lower-glycemic carbohydrates, pairing carbs with protein or fat, and keeping portions moderate. Walking for even 15 to 20 minutes after a meal can measurably flatten the post-meal glucose curve.

Nutritional research continues to explore specific food interventions. A small randomized trial found that a 12-week intervention with specially enriched eggs improved fasting glucose and markers of insulin resistance in people with type 2 diabetes, though this kind of single-food study is difficult to generalize.²⁶ The broader takeaway is that dietary improvements and regular movement, together, are often enough to pull a 6.8% A1C below the 6.5% diagnostic threshold or into a comfortable zone below the 7.0% treatment target. For many people, that half-percentage-point difference between “close to target” and “at target” is achievable without adding or changing medications, though that conversation belongs with your care team.